Navigation Links
First-ever Compounds To Target Only Metastatic Cells Are Highly Effective Against Breast, Prostate, And Colon Cancers

Two compounds that zero in on cancer cells spreading throughout the body, while ignoring primary tumor cells, could someday give doctors a whole new weapon in the fight against tough-to-treat metastatic disease, according to Weill Medical College of Cornell University researchers.

The compounds, called synthetic migrastatin analogues, prevented 91 to 99 percent of metastatic breast cancer cells in mice, and are the first to target only metastatic cells.

"They're unbelievably effective, and in vitro study suggests they'll work just as well at inhibiting the migration of prostate and colon cancer cells," said senior researcher Dr. Xin-Yun Huang, Professor of Physiology and Biophysics at Weill Cornell Medical College in New York City.

The findings have just been published in Proceedings of the National Academy of Sciences.

For decades, doctors have fought cancer by using surgery, chemotherapy, or radiation to excise or shrink the primary tumor.

"However, in too many cases it's simply impossible to completely remove the tumor," Dr. Huang explained. "So recently the idea of targeting cell migration -- metastasis -- has become an alternative strategy that's gained a lot of interest among researchers."

If compounds could be found that slowed or halted cancer spread, doctors could gain valuable time in shrinking the primary tumor. "If we had the luxury of time, we could treat that primary tumor at lower doses, too, with fewer side effects for the patient," Dr. Huang said.

Until now, agents that specifically target metastatic cells have remained elusive. However, a new avenue of research opened up when Dr. Huang's team noticed that the Streptomyces bacterium -- the bug that gives us the antibiotic streptomycin -- also produces a natural compound called migrastatin, which appears to inhibit cell migration.

Natural migrastatin's effect is relatively weak, but Dr. Huang suspected the molecule might be manipulated in
'"/>

Source:Cornell University


Page: 1 2 3

Related biology news :

1. First-ever genomic test predicts which lung cancer patients need chemotherapy to live
2. Compounds in plastic packaging act as environmental estrogens altering breast genes
3. Novel Enzyme Shows Potential As An Anti-HIV Target
4. Potential Drug Target For Treating Cocaine Abuse Found
5. Affymetrix and ParAllele Launch Industrys Most Comprehensive Product Line for Targeted Genotyping
6. Targeting a key enzyme with gene therapy reversed course of Alzheimers disease in mouse models
7. New Therapeutic Target Identified In Inherited Brain Tumor Disorder
8. Targeted drug delivery achieved with nanoparticle-aptamer bioconjugates
9. Targeted virus compels cancer cells to eat themselves
10. Best of both worlds -- Targeting a single gene could inhibit bone decay and stimulate bone growth
11. Targeting tumors the natural way
Post Your Comments:
(Date:6/17/2013)... As mobile devices, smartphones and tablets ... grows exponentially, and biometric authentication offers that security, ... Reading Insider ( www.heavyreading.com/mobile-networks ), a subscription ... www.heavyreading.com ). Biometrics Offer Promise for ... authentication on smartphones, analyzing the most lucrative verticals ...
(Date:6/17/2013)... MANHATTAN, KAN. -- A Kansas State University research associate ... on mosquitoes and ways to prevent the spread of ... received the National Institutes of Health,s National Research Service ... years. He is the seventh Kansas State University researcher ... on campus to currently hold such an award. , ...
(Date:6/17/2013)... declining worldwide and a major cause is a deadly ... two-year study shows they can also die from this ... carrier host that just spreads the disease. , When ... conditions, they found at least one strain of this ... a chytrid fungus, can be fatal to year-old juveniles. ...
Breaking Biology News(10 mins):Biometric Authentication Provides Better Mobile Device Security, Heavy Reading Finds 2Biometric Authentication Provides Better Mobile Device Security, Heavy Reading Finds 3NIH fellowship helps researcher fight malaria, understand mosquito immunity 2Bullfrogs may help spread deadly amphibian fungus, but also die from it 2
... Trust researchers have identified a key gene involved in the ... mostly women. The lead researcher behind the study has called ... to further study the underlying causes of the disease. ... autoimmune disease which frequently causes skin rash, joint pains and ...
... to differentiate metastatic cancer cells from normal cells in ... of the cells. The study, published Dec. 2, ... Nature Nanotechnology, represents one of the first times researchers ... patients and apply nanotechnology to analyze them and determine ...
... whose skulls were made whole again by bone tissue ... Healing critical-size defects (defects that would not otherwise heal ... type that forms the skull, is a vivid demonstration ... University to use hESCs for tissue regeneration. ...
Cached Biology News:Lupus gene finding prompts call for more DNA samples 2Using nanotechnology, UCLA researchers discover cancer cells 'feel' much softer than normal cells 2Using nanotechnology, UCLA researchers discover cancer cells 'feel' much softer than normal cells 3Using nanotechnology, UCLA researchers discover cancer cells 'feel' much softer than normal cells 4Human embryonic stem cell -- derived bone tissue closes massive skull injury 2
(Date:6/18/2013)... June 18, 2013  AMRI (NASDAQ: ... Burlington, Mass. , site has received approval ... (DEA) registration to handle Schedule 2 and 2N ... of Burlington,s physical security ... (Logo: http://photos.prnewswire.com/prnh/20120229/NY61160LOGO ) ...
(Date:6/18/2013)... 18, 2013 Research ... the addition of the report " DNA ... to their offering.      (Logo: ... basics of human genome variations, development of ... and small sequencers are described as well ...
(Date:6/18/2013)... 2013 Though health care jobs ... the U.S. Bureau of Labor Statistics -- the increase was ... month. Most new health care jobs were added in home ... a loss of 6,000 jobs. Overall, the U.S. unemployment rate ... Gray & Christmas reported that a total of just over ...
(Date:6/18/2013)... June 18, 2013 ActiGraph, a leading ... for the global research community, announced today that Dr. ... Dr. Matsudo is the Scientific Director of the Physical ... a Professor of Medicine at Gama Filho University and ... by the State Secretariat of Health of São Paulo ...
Breaking Biology Technology:AMRI Burlington Receives DEA Approval to Handle Controlled Substances 2DNA Sequencing: Technologies, Markets and Companies - 2013 Report 2MedZilla Employment Report for June 2013 -- Jobs in Health Care Grow, But at Slower Pace 2MedZilla Employment Report for June 2013 -- Jobs in Health Care Grow, But at Slower Pace 3Dr. Victor KR Matsudo Joins ActiGraph Scientific Advisory Board 2
... The American Chamber of Commerce in Spain (AmChamSpain) ... Victor Grifols Roura, as the winner of its ... to recognize the international efforts of business leaders, ... responsible economic globalization. (Logo: http://photos.prnewswire.com/prnh/20110304/PH59473LOGO) ...
... -- Using minute graphite particles 1000 times smaller than the ... University hope to boost the efficiencyand profitabilityof solar power plants. ... more on rooftops, but they,re not necessarily the best solar ... they can use only a fraction of the sunlight that ...
... 2011 Neurocrine Biosciences, Inc. (NASDAQ: NBIX ) ... preliminary assessment of the initial cohort of Tardive Dyskinesia ... (VMAT2), NBI-98854. Based on this data, the Company is ... the U.S. Food and Drug Administration (FDA). ...
Cached Biology Technology:The American Chamber of Commerce in Spain Awards the Global Business Leader Award 2011 to Victor Grifols Roura, President and CEO of Grifols 2The American Chamber of Commerce in Spain Awards the Global Business Leader Award 2011 to Victor Grifols Roura, President and CEO of Grifols 3Nanoparticles improve solar collection efficiency 2Neurocrine Biosciences Announces Successful Phase IIa Clinical Trial for VMAT2 Inhibitor 2Neurocrine Biosciences Announces Successful Phase IIa Clinical Trial for VMAT2 Inhibitor 3Neurocrine Biosciences Announces Successful Phase IIa Clinical Trial for VMAT2 Inhibitor 4
... Continuous flow of media and other ... little lab space, The speed of each ... and flow set points, are exactly maintained. ... equipped with variable tube types, which allows ...
... An excellent ion chromatography system . ... twelve ranges from 0.01S to 5000S, houses the ... suppressor module CE 4715, is available. Data ... and software., Solvent delivery is by the high ...
Fujifilm Pictro-Color Process for sharp, clear reproduction comparable to silver-halide photography. Photorealistic 400 dpi quality. A4 and A5 output....
... flow of media and other fluid sources ... space, The speed of each individual pump ... set points, are exactly maintained. ,High-precision ... variable tube types, which allows flow rates ...
Biology Products: